Repligen Corp
(NAS:RGEN)
$
154.86
0.16 (0.1%)
Market Cap: 8.68 Bil
Enterprise Value: 8.56 Bil
PE Ratio: 0
PB Ratio: 4.30
GF Score: 94/100 
Repligen Corp at SVB Leerink Global Healthcare (Virtual) Transcript
Feb 18, 2022 / 08:00PM GMT
Release Date Price:
$180.68
(-0.95%)
Puneet Souda
SVB Leerink LLC, Research Division - Senior MD of Life Science Tools and Diagnostics & Senior Research Analyst
All right. Great. Welcome, everyone. Back to SVB Leerink Global Healthcare Conference. I'm Puneet Souda, I cover life science tools and diagnostics. And literally, and I mean it, saving the best for last. It's really wonderful to have team Repligen joining us. Tony Hunt, CEO; and Jon Snodgres, CFO. Wonderful to have you guys here.
Anthony J. Hunt
Repligen Corporation - CEO, President & Director
Yes. Thanks, Puneet.
Jon K. Snodgres
Repligen Corporation - CFO
Good to be here.
Puneet Souda
SVB Leerink LLC, Research Division - Senior MD of Life Science Tools and Diagnostics & Senior Research Analyst
Okay. Excellent. So just sort of [2 sense] from my side. I mean Repligen is really a high-growth company in bioprocessing markets that's benefiting from core mAb expansion cell and gene therapy expansion and then vaccine and therapeutic
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers